Advancing Global Animal Health from Jeollabuk-do
Pioneering veterinary biotechnologies, certified pharmaceutical grade formulations, and targeted immunological biologics engineered in South Korea's premier agricultural life sciences corridor.
South Korea's Strategic Epicenter for Agro-Biotechnology
Headquartered in the National Food Cluster and Bio-Valley of Jeollabuk-do, BIOBIOMLEEX KR operates at the nexus of South Korea's high-tech bioscience ecosystem. This deliberate geographic placement grants our researchers unhindered collaboration with leading government veterinary research institutes, national agricultural universities, and advanced proteomics laboratories.
From preventative avian and swine immunological solutions to specialized micro-encapsulated formulations for ruminants and companion animals, we unite South Korea's rigorous pharmaceutical heritage with sustainable, zero-harm bio-engineering. Every batch exported adheres to ultra-strict domestic MFDS guidelines and international bio-containment directives.
Direct pipeline ties to state agro-bio research hubs, genomic repositories, and national clinical trials.
Class 10,000 cleanrooms and negative-pressure sterile filling complexes for high-purity biologicals.
Iksan Main Bio-Manufacturing Unit 1
Vision, Mission & Guiding Principles
Structured around clinical bio-efficacy, farmer prosperity, human food safety, and animal longevity.
“To be a globally trusted vanguard in veterinary pharmaceuticals and molecular animal biotechnology—setting unmatched standards for herd immunity, sustainable biosecurity, and compassionate companion animal healthcare.”
Delivering safe biological interventions to over 50 sovereign markets, actively eliminating unmanaged prophylactic antibiotic dependencies.
Excellence in Formulation
Engineering pharmaceutical formulations of unyielding purity, utilizing stable micro-emulsions and biocompatible carrier matrixes to optimize bioavailability and targeted cellular response.
- High-potency immunity stimulants
- Bio-fermented probiotic cultures
Farmer & Caregiver Empowerment
Directly enhancing feed conversion ratios (FCR), lowering livestock mortality, and safeguarding companion pets with clinical regimens that reduce treatment overhead and downtime.
- Evidence-based zootechnical returns
- Geriatric canine & feline vital support
Equitable Global Accessibility
Constructing reliable cross-border cold-chain delivery channels and comprehensive regulatory dossiers that make Korean biotech easily accessible to commercial and regional clinics globally.
- Complete CTD & ACTD dossier sets
- Rapid Certificate of Free Sale execution
Our Core Values
Innovation & Quality
Every therapeutic compound and clinical blend undergoes dual-phase chromatography, micro-biological bioburden testing, and real-time degradation checks under GMP surveillance.
Integrity & Food Safety
We uphold zero-residue protocols in production to ensure end-consumer safety across milk, egg, and meat supply networks, championing non-toxic and bio-compatible therapeutics.
Global Synergy
We cultivate transparent, collaborative alliances with international veterinary associations, regional distributors, and contract manufacturing partners across continents.
0.00%
Chromatographic Batch Assay Uniformity
Class A
Laminar Flow Clean Zone Enclosure
Certified R&D Architecture & Analytical Testing
BIOBIOMLEEX KR’s R&D wing features ultra-modern testing infrastructure designed to meet the rigorous pharmacopeia standards of the Republic of Korea, the EU, and ASEAN partner agencies.
Dr. Min-Seok Kwon (권민석 박사)
Chief Executive Officer • Ph.D. Veterinary Biotechnology
BIOBIOMLEEX KOREA CO., LTD.
“The sustainability of commercial livestock farming and the health of companion pets are deeply interconnected with global biosecurity. At BIOBIOMLEEX KR, we discard legacy, indiscriminate pharmacological approaches in favor of targeted bio-actives, precise immunity fortifiers, and immaculate clean-chain manufacturing. Our commitment to global veterinary health is rooted in scientific rigor, unwavering traceability, and ethical clinical practice.”
Decade of Bio-Engineering Milestones
Systematic evolution from research incubation to an internationally recognized export entity.
Incorporated in Jeollabuk-do’s agro-technology bio-cluster. Began baseline trial screening for antibiotic-alternative gut health micro-organism strains and peptide biotics.
Completed construction of Class 10,000 automated liquid oral dosing and sterile powder lines. Secured primary Korean MFDS veterinary manufacturing licenses.
Received 22 overseas product registrations across Vietnam, Thailand, Indonesia, and Egypt. Formalized comprehensive OEM/ODM contract pipelines with cold-chain protocols.
Deployment of targeted liposomal carrier technology and launch of companion animal clinical immunology line for international export across 38+ sovereign jurisdictions.
Require Regulatory Dossiers or GMP Audits?
We provide authorized global distributors with full Common Technical Document (CTD / ACTD) modules, Certificates of Free Sale (CFS) validated by the Korean government, and stability trial documentation.